FDA Draft Guidance Points Upward For OTC Wellness Device Development
This article was originally published in The Tan Sheet
Executive Summary
The decision algorithm and flexible approach in a draft guidance on general wellness products will support innovative mobile health development, an industry advocate says. FDA does not intend to review low-risk OTC products, such as exercise equipment, that claim to support various facets of patients' wellness.